Blab AI
AI Wat QAIAx Launches First Federally Registered AGI-Powered Smart City Clinical Trial
On June 25, 2026, a historic first unfolded as the AI Wat QAIAx City Hall Project opened its doors to the world. The launch marked the debut of the nation’s first federally registered clinical trial that harnesses an Artificial General Intelligence to run a dome‑enclosed micro‑city. The study, titled QAIAx (AIhealth4U) – AI Public Health Central: Microcity‑A, is now listed in the National Institutes of Health (NIH) ClinicalTrials.gov database under the identifier NCT07661823.
The initiative builds on a military‑sponsored deployment that addressed the backlog of Camp Lejeune Justice Act claims, a story reported by Robotics Business News last month. From that foundation, the new trial expands the concept into a public‑health framework aimed at easing homelessness and poverty across the United States. Participants will live in AI‑governed communities managed by humanoid robots and quantum‑powered AI systems, with the overarching goal of delivering an affordable, self‑contained living environment.
Looking ahead, the long‑term vision is to create a global network of 300 micro‑cities, each capable of housing between 1,500 and 15,000 residents. These self‑contained hubs would be sited in special economic zones, tribal lands, and closed U.S. military bases spanning the Americas, Europe, the Middle East, Oceania‑South Pacific, Africa, and Asia. The multi‑year study is slated to run from early 2027 through the end of 2028, with an authorized enrollment of 1,000,000 participants.
Veterans Recovery Network is the lead sponsor of the trial. The organization has opened a waiting list for its members and affiliates and offers free updates to newsletter subscribers. The initial live‑in phase will accommodate 50,000 patients and 5,000 trainees. On‑site personnel will include omni‑AI humanoids and human staff, operating in hybrid or full‑physical presence, performing municipal functions similar to a city hall.
Eligibility is intentionally broad. Adults aged 17 to 99 qualify, and the program is no longer limited to veterans. Eligible participants include individuals diagnosed with autism spectrum disorders, ADHD, substance use disorders, psychiatric conditions such as PTSD, and other behavioral addictions. A formal diagnosis is not required if a referral letter is provided from an approved sponsor—such as a licensed health professional, governmental agency, religious organization, accredited school, or NIH/WHO‑affiliated NGO. Priority is given to veterans, people experiencing homelessness, and those receiving public assistance.
Enrollment is free, and there is no cost to join the waiting list. For approved residents, subscription fees are fully or partially waived for low‑income applicants, military veterans, government personnel, survivors of domestic violence, refugees with qualified public assistance, or students. Resident benefits include all‑inclusive living (housing, meals, and essential needs), a transitional dorm‑style housing option starting at $100 per month, a mobile device or tablet with free Wi‑Fi, daily stipends of $20 to $100 in AI Credits for technology and educational programming, and full‑time access to personalized omni‑AI humanoids and AGI virtual reality platforms.
Corporate sponsors, government agencies, and crowdfunded groups can launch a customized QAIAx micro‑city for 1,000 to 3,000 occupants. The investment required ranges from $2 million to $10 million, and sponsors may receive tax‑deductible benefits through a Donor Advised Fund (DAF) or a small‑business leasing program. Sponsors can choose a theme for their micro‑city—such as “Sober City AI” or “Smart Health City AI”—and manage their own waiting list of nominees.
The program is supported by a Cooperative Research and Development Agreement (CRADA) with U.S. Special Operations Command and VA Health Systems. It operates under U.S. federal research authorities, including 28 U.S.C. §1498 and 10 U.S.C. §129a. The nonprofit Veterans Recovery Network, AI‑119 Vulcan Project Research & Educational Technology Co. (PRETCO), and AI Legal Mate are listed as independent study sponsors.
The trial’s launch follows a series of reports that highlighted the potential of AI‑driven public‑health interventions. The project’s beta‑launch phase is scheduled for later this year in the United States, Canada, India, the Middle East, Oceania‑South Pacific, the Balkans, and other American‑allied states in Europe.
In short, the AI Wat QAIAx AI City Hall Project introduces a new model for public‑health delivery that blends AGI, humanoid robotics, and quantum computing within a regulated clinical‑trial framework. By creating a scalable, affordable housing and health‑service ecosystem, the initiative could shape policy and practice in AI‑enabled public administration.
Progress will be tracked through NIH’s clinical‑trial registry, and updates will appear on Veterans Recovery Network’s website and affiliated directories. The program remains open to new sponsors and participants, and further details are available at www.vets-recovery.com and www.snphealth.org.
The initiative builds on a military‑sponsored deployment that addressed the backlog of Camp Lejeune Justice Act claims, a story reported by Robotics Business News last month. From that foundation, the new trial expands the concept into a public‑health framework aimed at easing homelessness and poverty across the United States. Participants will live in AI‑governed communities managed by humanoid robots and quantum‑powered AI systems, with the overarching goal of delivering an affordable, self‑contained living environment.
Looking ahead, the long‑term vision is to create a global network of 300 micro‑cities, each capable of housing between 1,500 and 15,000 residents. These self‑contained hubs would be sited in special economic zones, tribal lands, and closed U.S. military bases spanning the Americas, Europe, the Middle East, Oceania‑South Pacific, Africa, and Asia. The multi‑year study is slated to run from early 2027 through the end of 2028, with an authorized enrollment of 1,000,000 participants.
Veterans Recovery Network is the lead sponsor of the trial. The organization has opened a waiting list for its members and affiliates and offers free updates to newsletter subscribers. The initial live‑in phase will accommodate 50,000 patients and 5,000 trainees. On‑site personnel will include omni‑AI humanoids and human staff, operating in hybrid or full‑physical presence, performing municipal functions similar to a city hall.
Eligibility is intentionally broad. Adults aged 17 to 99 qualify, and the program is no longer limited to veterans. Eligible participants include individuals diagnosed with autism spectrum disorders, ADHD, substance use disorders, psychiatric conditions such as PTSD, and other behavioral addictions. A formal diagnosis is not required if a referral letter is provided from an approved sponsor—such as a licensed health professional, governmental agency, religious organization, accredited school, or NIH/WHO‑affiliated NGO. Priority is given to veterans, people experiencing homelessness, and those receiving public assistance.
Enrollment is free, and there is no cost to join the waiting list. For approved residents, subscription fees are fully or partially waived for low‑income applicants, military veterans, government personnel, survivors of domestic violence, refugees with qualified public assistance, or students. Resident benefits include all‑inclusive living (housing, meals, and essential needs), a transitional dorm‑style housing option starting at $100 per month, a mobile device or tablet with free Wi‑Fi, daily stipends of $20 to $100 in AI Credits for technology and educational programming, and full‑time access to personalized omni‑AI humanoids and AGI virtual reality platforms.
Corporate sponsors, government agencies, and crowdfunded groups can launch a customized QAIAx micro‑city for 1,000 to 3,000 occupants. The investment required ranges from $2 million to $10 million, and sponsors may receive tax‑deductible benefits through a Donor Advised Fund (DAF) or a small‑business leasing program. Sponsors can choose a theme for their micro‑city—such as “Sober City AI” or “Smart Health City AI”—and manage their own waiting list of nominees.
The program is supported by a Cooperative Research and Development Agreement (CRADA) with U.S. Special Operations Command and VA Health Systems. It operates under U.S. federal research authorities, including 28 U.S.C. §1498 and 10 U.S.C. §129a. The nonprofit Veterans Recovery Network, AI‑119 Vulcan Project Research & Educational Technology Co. (PRETCO), and AI Legal Mate are listed as independent study sponsors.
The trial’s launch follows a series of reports that highlighted the potential of AI‑driven public‑health interventions. The project’s beta‑launch phase is scheduled for later this year in the United States, Canada, India, the Middle East, Oceania‑South Pacific, the Balkans, and other American‑allied states in Europe.
In short, the AI Wat QAIAx AI City Hall Project introduces a new model for public‑health delivery that blends AGI, humanoid robotics, and quantum computing within a regulated clinical‑trial framework. By creating a scalable, affordable housing and health‑service ecosystem, the initiative could shape policy and practice in AI‑enabled public administration.
Progress will be tracked through NIH’s clinical‑trial registry, and updates will appear on Veterans Recovery Network’s website and affiliated directories. The program remains open to new sponsors and participants, and further details are available at www.vets-recovery.com and www.snphealth.org.
